This document establishes performance measures for the referral to and delivery of cardiac rehabilitation services to improve outcomes in patients with cardiovascular disease.
Answers are grounded in this paper and cite their sources.
These performance measures should now guide cardiac rehabilitation referral and delivery; extends prior guidelines by standardizing quality metrics for cardiovascular care.
PREAMBLE Medicine is experiencing an unprecedented focus on quantifying and improving healthcare quality. The American College of Cardiology (ACC) and the American Heart Association (AHA) have developed a multifaceted strategy to facilitate the process of improving clinical care. The initial phase of this effort was to create clinical practice guidelines that carefully review and synthesize available evidence to better guide patient care. Such guidelines are written in a spirit of suggesting diagnostic or therapeutic interventions for patients in most circumstances. Accordingly, significant judgment by clinicians is required to adapt these guidelines for the care of individual patients, and these guidelines can be generated with varying degrees of confidence on the basis of available evidence. Occasionally, the evidence supporting a particular structural aspect or process of care is so strong that failure to perform such actions reduces the likelihood that optimal patient outcomes will occur. Creating a mechanism for quantifying these opportunities to improve the outcomes of care is an important and pressing challenge. In the next phase of its quality improvement (QI) efforts, the ACC and the AHA created the ACC/AHA Task Force on Performance Measures in February 2000 to spearhead the development of performance measures that allow the quality of cardiovascular care to be assessed and improved. Three nominees from each organization were charged with the task of assembling teams of clinical and methodological experts, both from within the sponsoring organizations and from other organizations dedicated to the care of patients covered by the performance measurement set. These writing committees were given careful guidance with respect to the necessary attributes of good performance measures and the process of identifying, constructing, and refining these measures so that they can accurately achieve their desired goals.1 The role of performance measurement writing committees is not to perform a primary evaluation of the medical literature; this is undertaken by ACC/AHA guidelines committees. However, performance measurement writing committees work collaboratively with guidelines committees so that the guideline recommendations are written with a degree of specificity that supports performance measurement and so that new knowledge can be rapidly incorporated into performance measurement. Development of the ACC/AHA guidelines includes a detailed review of and ranking of the evidence available for the diagnosis and treatment of specific disease areas. Published guideline recommendations employ the ACC/AHA classification systems I, IIa, IIb, and III (Table 1).Table 1: • APPLYING CLASSIFICATION OF RECOMMENDATIONS AND LEVEL OF EVIDENCEaSo as not to duplicate performance measure development efforts, writing committees were also instructed to evaluate existing nationally recognized performance measures using the ACC/AHA “attributes of good performance measures.” The measure specifications were adopted for those performance measures that meet these criteria. Such measures have established validity, reliability, and feasibility and would form the foundation of the ACC/AHA measurement sets. Furthermore, writing committees are encouraged to identify additional performance measures that correspond to those key areas of quality proven to improve patient outcomes. The ACC/AHA Performance Measurement Sets are to be applied in the inpatient and/or outpatient setting depending upon the topic. Although inpatient measures have traditionally been captured by retrospective data collection, the increased use of electronic medical records allows for prospective collection in the inpatient and outpatient settings. Prospective data collection is itself a continuous QI process. The performance measures quantify explicit actions performed in carefully specified patients for whom adherence should be advocated in all but the most unusual circumstances. In addition, the measures are constructed with the intent to facilitate both retrospective and prospective data collection using explicit administrative and/or easily documented clinical criteria. Furthermore, the data elements required to construct the performance measures are identified and linked to existing ACC/AHA Clinical Data Standards to encourage the standardization of cardiovascular measurement. Although the focus of the performance measures writing committees is to develop measures for internal QI, it is appreciated that other organizations may use these measures for external reporting of provider performance. Therefore, it is within the scope of the writing committee's task to comment on the strengths and limitations of externally reporting potential performance measures. Specifically, this was done in the “Challenges to implementation” sections in each of the performance measures when appropriate (see Appendixes A and B). All the measures contained in this set have limitations and challenges to implementation that could result in unintended consequences when used for accountability purposes. The implementation of these measures for purposes other than QI require field testing to address issues related to, but not limited to, sample size, reasonable frequency of use for an intervention, comparability, and audit requirements. The way in which these issues are addressed would be highly dependent on the type of accountability system developed, including data collection method, assignment of patients to physicians for measurement purposes, baseline measure setting, incentive system, and public reporting method among others. The ACC/AHA encourages those interested in working on implementation of these measures for purposes beyond QI to work with the ACC/AHA to understand these complex issues in pilot testing projects that can measure the impact of any limitations and provide guidance on possible refinements of the measures that would make them more suitable for additional purposes. In the process of facilitating the measurement of cardiovascular healthcare quality, the ACC/AHA Performance Measurement Sets can serve as a vehicle for more rapidly translating the strongest clinical evidence into practice. These documents are intended to provide practitioners with “tools” for measuring the quality of care and for identifying opportunities to improve. Because the target audience and unit of analysis for these measures is the practitioner, they were constructed from the provider's perspective and were not intended to characterize “good” or “bad” practice but to be part of a system with which to assess and improve healthcare quality. It is our hope that an application of these performance measures within a system of QI will provide a mechanism through which the quality of medical care can be measured and improved. Robert O. Bonow, MD, FACC, FAHA, FACP Chair, ACCF/AHA Task Force on Performance Measures Over the past 4 decades, cardiac rehabilitation/secondary prevention (CR) services have become recognized as a significant component in the continuum of care for persons with cardiovascular disease (CVD). The role of CR services in the comprehensive secondary prevention of CVD events is well documented2–12 and has been promoted by various healthcare organizations and position statements.4,12–18 However, performance measures for CR services have not been published to date. To formalize performance measures for CR services, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)/American College of Cardiology (ACC)/American Heart Association (AHA) Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee was convened in November 2005. The writing committee was given the charge of developing performance measures that cover 2 specific aspects of CR services: (1) referral of eligible patients to a CR program; and (2) delivery of CR services through multidisciplinary CR programs. The ultimate purpose of these performance measure sets is to help improve the delivery of CR to reduce cardiovascular mortality and morbidity and optimize health in persons with CVD, including acute myocardial infarction (MI) or status post coronary artery bypass graft (CABG) surgery, percutaneous coronary intervention (PCI), stable angina, and heart transplantation or heart valve surgery. Using the previously published methodology of the ACC and the AHA,1,19 performance measures for the referral of eligible patients to a CR program and the delivery of CR services through multidisciplinary CR programs were developed, focusing on processes of care that have been documented to help improve patient outcomes (using the ACC/AHA system for classification of recommendations and level of evidence for guidelines and clinical recommendations shown in Table 1). Both inpatient and outpatient settings of cardiovascular care were considered, resulting in performance measures being created for 3 specific settings: (1) hospitals; (2) office practices; and (3) CR programs. Rationale for CR Performance Measures/Secondary Prevention The rationale for developing and implementing performance measure sets for referral to and delivery of CR services is based on several key factors: There has been growing scientific evidence over the past 3 decades on the benefits of CR services for persons with CVD.2,17,20 Evidence suggests that the benefits of CR services are as significant in recent years as they were in the prethrombolytic era.9,21 Because of this mounting evidence, a number of healthcare organizations have endorsed the use of CR services in persons with CVD by including provisions for CR in their practice guidelines and practice management position papers.4,12,13,18,21–23 Despite both the known benefits of CR and the widespread endorsement of its use, CR is vastly underutilized, with less than 30% of eligible patients participating in a CR program after a CVD event.24–26 Reasons for this gap in CR participation are numerous, but the most critical and potentially most correctable reasons revolve around obstacles in the initial referral of patients to CR programs. These obstacles can be reduced through the systematic adoption of standing orders and other similar tools for CR referral for appropriate hospitalized patients.27 Furthermore, physician accountability associated with the use of these performance measures may lead to new and novel approaches to improve both referral rates and the outcome of patients with CVD. Standards for CR programs have been previously published,28 and systems for CR program certification exist, such as the certification process offered through the AACVPR for CR programs that meet its standards of practice. Unfortunately, since such certification is not required for CR program operation or for reimbursement purposes, CR program certification is obtained by a relatively small portion of CR programs in the United States. As of October 2006, only 973 (37%) of an estimated 2,621 CR programs operating in the United States have AACVPR certification29 (A. Lynn, personal communication, October 31, 2006). Recommendations for CR referral and participation are included in many practice guidelines and position papers regarding the care of persons with CVD, but to date, no groups have included referral to CR services in their CVD-related performance measure sets. Likewise, there are no currently available performance measure sets that include measures for the delivery of CR services by outpatient CR programs. Clearly, there is a need and also a prime opportunity to reduce the gap in delivery of CR services to persons with CVD. Such an improvement in CR delivery will require better approaches in the referral to, enrollment in, and completion of programs in CR. It is anticipated that the implementation of CR performance measure sets will stimulate changes in the clinical practice of preventive and rehabilitative care for persons with CVD. Writing Committee Structure and Members To formalize performance measures for CR services, the AACVPR/ACC/AHA Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee was convened in November 2005. The writing committee was composed of nominated representatives from the the and the including past and representatives of the ACC Task Force on Performance past and of the and clinicians with in clinical heart CVD, and CR. initial committee was in on and Committee were by Committee their to in the writing committee and any potential of The the and the AHA the of both the initial committee in and was for any aspect of the committee's and A public comment was for this from 2006, were to provide on the on the basis of the form and guide shown in were and incorporated into a of the and of the of the was obtained through the from the the and the of the was from key of CR Over the past various CR program delivery have from the programs within a CR and patients in of these programs include those outpatient programs provide CR services to patients through novel such as those that are or The for CR in use is based on a from the of the that CR is an component in the management of patients with CVD, that the patient a significant role in the outcome of and that CR is an important of services the secondary prevention of CVD on this a number of other of CR have been by various organizations including the the the and the Association of Cardiac These the role of CR in the secondary prevention of CVD. The used by the and by the Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee is as Cardiac services are programs medical cardiac and These programs are to the and of cardiac reduce the for or cardiac or the and the and status of CR programs are into 3 CR known as phase A program that preventive and rehabilitative services to hospitalized patients an CVD such as an coronary outpatient CR known as phase A program that preventive and rehabilitative services to patients in the outpatient setting after a CVD within the 3 to after the but for as as after the outpatient CR known as phase III or phase A program that delivery of preventive and rehabilitative services for patients in the outpatient The focus of this position is on the referral to and delivery of outpatient CR services it is the component of CR that has been most documented to help reduce the of CVD mortality among its of for CR are eligible for CR include those have or more of the as a primary diagnosis within the coronary Heart valve or Heart or transplantation The of this is on the management of persons with coronary artery in the with an but CR services are appropriate and for persons (1) after heart valve or and (2) after heart or transplantation previously Furthermore, growing evidence from published supports a CR for persons with heart failure or However, recommendations by healthcare organizations to and/or cover CR services in these patient will upon in the of heart the of are potentially eligible for CR in have that their participation in CR. Such include those that are patient that are provider the patient for CR to a medical and/or an to and that are related to the healthcare system and/or of a CR of with such may be from the number of patients are to be eligible for CR referral the for the of eligible patients have been to a CR It should be that persons may have significant or to CR all patients with CVD could from of a secondary prevention CR of Performance Measures Both and performance measures are included in the Cardiac Prevention Performance Measurement important and specific measures on clinical outcomes are not The performance measures that are included are to help healthcare groups identify potentially correctable and of clinical such as and in CR for the of care included in the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets are as measures quantify the from which CR is and are based on the of appropriate and to standards of care for CR a performance measure for a CR program is that that a CR program has appropriate and to provide care in medical that may CR program measures quantify specific aspects of care and are to all of CR care. a performance measure for a CR program is that that all patients in a CR program of their cardiovascular upon to the CR It should also be that the Cardiac Prevention Performance Measurement Sets have been for 3 settings of (1) the (2) the physician and (3) the CR program settings. within each of these areas help provide care to persons with CVD are for the various aspects of CR services to, enrollment in, and delivery of CR and Evidence There is evidence to that CR is reasonable and necessary surgery, stable angina, heart valve or and heart or as by the is a intervention including medical cardiac and to 3 after and including of patients (see of and systematic provide and the evidence that has been generated from published clinical that CR services are for patients with established CVD. These benefits include processes of care and that are linked to mortality and data from clinical of CR a mortality of to and a in over a of and of Measures The Cardiac Rehabilitation/Secondary Prevention Performance Writing Committee identified from various practice guidelines and other that were potential performance measures for the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets (see Table for guidelines that were used to the classification of recommendations and level of evidence for these The these to guidelines established by the ACC/AHA Task Force on Performance measures that were to be most and were included in the performance measurement sets. these measures were the writing committee and over a of the and other of each of the measures. most performance measures are for a specific and phase of a particular CR referral is and appropriate for a number of and of CVD. Accordingly, the writing committee created 2 sets of performance related to the appropriate referral of patients to a CR program and set related to optimal performance of a CR program In the the writing committee to create a measure that would be appropriate for into other performance measurement sets for which CR referral would be appropriate performance measurement sets for care of patients or the organization of these 2 of measures and their intended 1: application of the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets A and the the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets A and and the patient for which the performance measurement sets coronary artery bypass myocardial percutaneous coronary CR The performance measures that are related to the referral of appropriate patients to an outpatient CR program are in the next and are appropriate for referral to an outpatient CR program include those patients in the have any of the in the of appropriate patients for The CR services are most when after the However, there are and reasons that enrollment in CR. this many allow CR services to to to a cardiac Because patients can be to CR varying a CVD for the referral of patients to CR include and healthcare systems as well as physician and other healthcare settings with primary for the care of patients after a CVD of the Measures The Cardiac Rehabilitation/Secondary Prevention Performance Measurement A is based on 2 for the appropriate referral of patients to an outpatient CR all hospitalized patients with a CVD are to an outpatient CR program to and all with a diagnosis within the past have not in an outpatient CR program are to an outpatient CR program by their healthcare It should be that the healthcare system and its care for patients and/or after CVD events are for these performance measures. or other healthcare patients with CVD but not have a primary role in their CVD are not for these criteria. an is an on a patient in the after or would not be for the patient to a CR regarding this performance measurement set are included in Data of tools that may be of help in the Cardiac Rehabilitation/Secondary Prevention Performance Measurement A into practice are included in 2 and 2 an of a CR referral that healthcare systems could potentially use in the inpatient setting, 3 an of a potential CR referral for outpatient practice settings. 4 an of a performance measure that can be used by healthcare systems an with the performance measure of CR referral included in the performance measurement These tools are given as and not as endorsed systems and are encouraged to develop and systematic tools that are most appropriate and most for their particular setting and patient of a referral for an inpatient to an outpatient CR to be for use with the Cardiac Rehabilitation/Secondary Prevention Performance Measurement with from cardiac rehabilitation/secondary prevention of referral for an outpatient to an outpatient CR for to an prevention program to be for use with the Cardiac Rehabilitation/Secondary Prevention Performance Measurement with from cardiac rehabilitation/secondary of a for the of appropriate prevention including referral to a CR for patients hospitalized with a Data collection to be for use with the Cardiac Rehabilitation/Secondary Prevention Performance Measurement from American Heart The coronary artery cardiac rehabilitation/secondary myocardial in Performance Measurement Sets The Cardiac Rehabilitation/Secondary Prevention Performance Measurement A is to be included in other related performance measurement sets for which referral to a CR program would be an appropriate component of care can be the performance measurement set for management of patients with CR The set of performance measures included in the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Measurement to the optimal and processes of care for CR programs and is in the next and are appropriate for into a CR program include persons years or the have or more of the in the of appropriate patients for are for CR services, by or (see the of appropriate patients for may be appropriate for enrollment in CR programs that adapt their services to a given or The of care for outpatient CR to 3 after the CVD and to 3 to The unit of analysis for the Cardiac Prevention Performance Measurement is the healthcare CR Therefore, the for the performance of outpatient CR services include of the CR program medical cardiovascular and other of the CR of the CR Measurement The Cardiac Rehabilitation/Secondary Prevention Performance Measurement for the delivery of CR services includes those measures that were by the writing committee to have the level of evidence and among its The measures include both and measures that are used to assess the and by CR Measures Performance A physician medical is for the program with appropriate and is available patient care Measures Performance and and of each for events A process to assess patients for changes in and evaluation of CVD Development of interventions for identified and of care with other healthcare Evidence of a to and program through analysis of a to assess completion of the of a to patient outcomes the completion of and methodology to program and quality improvement (QI) the detailed specifications for each outpatient performance Data The Cardiac Rehabilitation/Secondary Prevention Performance Measurement is intended to be used to review a internal with the ultimate of the QI process. To in data a data collection or is of such a collection is shown in Table • for the cardiac rehabilitation/secondary prevention performance measurement set • systems and are encouraged to develop and/or use a that to practice and The of the Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee was to address 2 in the quality of care for patients with referral rates to CR programs and the need for performance standards for such CR programs. a of patients CR services and secondary prevention services in to a number of and healthcare The writing committee performance measurement sets that healthcare CR program and of healthcare systems for the ultimate of eligible patients to the appropriate CR services a CVD The writing committee its on 2 performance measurement (1) referral of eligible patients to an outpatient CR program; and (2) delivery of appropriate CR services by CR programs. The performance measure is to be used as a component to other performance measurement sets for which CR referral is appropriate surgery, The performance measurement set is to and performance measures that serve as a for CR as they work to improve the quality of care to their patients with CVD and optimize their outcomes. The writing committee not include performance measures for all patient groups that may from CR services, but on those groups of patients with the most scientific evidence and other supporting evidence for benefits from CR. patient including those patients have heart valve or have heart or are also appropriate for CR In addition, there is growing evidence for the benefits of CR in persons with other cardiovascular including heart failure and As more evidence available for the benefits of CR in these patient they would be included in of the Cardiac Rehabilitation/Secondary Prevention Performance Measurement To be the recommendations of the writing committee would need to be and by healthcare healthcare health disease management and other groups in the healthcare field that have for the delivery of care to persons with CVD. Such should be part of an to and in patient optimize delivery of services, and improve health outcomes.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: